Diabetes and gum disease share a clinically significant bidirectional relationship that directly affects HbA1c control. People living with diabetes are two to three times more likely to develop periodontitis, whilst active gum infection can independently worsen blood glucose levels by driving systemic inflammation and insulin resistance. Understanding how HbA1c, periodontal health, and diabetes management are interconnected is essential for both patients and healthcare professionals. This article explores the mechanisms behind this link, what NHS and NICE guidance recommends, and the practical steps that can improve both gum health and long-term glycaemic control.

How Diabetes and Gum Disease Are Linked

Diabetes increases susceptibility to periodontitis two to three times through impaired white blood cell function, advanced glycation end-products, and reduced saliva production, whilst gum disease can in turn worsen glycaemic control.

Diabetes and gum disease (periodontitis) share a well-established bidirectional relationship, meaning each condition can worsen the other. People living with diabetes — whether type 1 or type 2 — are significantly more susceptible to oral infections, including gingivitis (early-stage gum inflammation) and periodontitis (a more advanced infection affecting the tissues and bone supporting the teeth), due to several interconnected mechanisms.

Elevated blood glucose levels impair the function of white blood cells (neutrophils), reducing the body's ability to fight bacterial infections in the gum tissue. High glucose also promotes the formation of advanced glycation end-products (AGEs), which trigger inflammatory responses in the periodontal tissues, damaging the ligaments and bone that support the teeth. Additionally, diabetes can reduce saliva production, creating a drier oral environment that allows harmful bacteria to thrive.

The prevalence of periodontitis is estimated to be two to three times higher in people with diabetes compared to those without the condition, according to BSP/EFP consensus guidance and Diabetes UK. Key risk factors that compound this vulnerability include:

• Poor glycaemic control (reflected by elevated HbA1c)

• Smoking, which independently worsens both conditions

• Duration of diabetes — longer duration increases periodontal risk

• Obesity, which promotes systemic inflammation

Recognising this link is clinically important. Periodontitis is now widely recognised as a diabetes-associated complication, alongside retinopathy, nephropathy, and neuropathy. Healthcare professionals and patients alike should be aware that oral health is an integral component of overall diabetes management, not a separate concern.

It is also worth noting that severe or refractory periodontitis in a person not known to have diabetes may warrant consideration of undiagnosed diabetes or impaired glucose regulation. Dental teams should consider liaising with the patient's GP for an HbA1c test where this is clinically appropriate.

The Role of HbA1c in Monitoring Diabetic Oral Health

Higher HbA1c values are associated with more severe periodontal disease and impaired healing; dental teams are encouraged to ask patients for their most recent HbA1c result as part of a comprehensive oral health assessment.

HbA1c (glycated haemoglobin) is the primary marker used to assess long-term blood glucose control in people with diabetes. It reflects average blood glucose levels over the preceding two to three months and is expressed as a percentage or in mmol/mol.

NICE guideline NG28 recommends an HbA1c target of 48 mmol/mol (6.5%) or below for most people with type 2 diabetes managed with lifestyle changes or metformin alone, though individual targets are personalised based on clinical circumstances. For adults with type 1 diabetes, NICE guideline NG17 recommends a target of 48 mmol/mol (6.5%) where this can be achieved safely, again with individual variation.

The relevance of HbA1c to oral health is direct and measurable. Studies consistently demonstrate that individuals with poorly controlled diabetes experience more severe periodontal disease, greater tooth loss, and slower healing following dental procedures. Conversely, those who maintain tighter glycaemic control tend to have healthier gum tissue and respond better to periodontal treatment. In general, higher HbA1c values are associated with greater periodontal risk and impaired healing, though the precise thresholds vary across studies and no UK guideline body has defined formal HbA1c-based periodontal risk bands.

Dentists and dental hygienists are increasingly encouraged — in line with BSP/EFP consensus recommendations — to ask patients about their most recent HbA1c result as part of a comprehensive oral health assessment. This integrated approach supports earlier identification of patients who may benefit from both intensified dental care and a review of their diabetes management with their GP or diabetes care team.

The frequency of dental recall should be determined on an individual, risk-based basis in accordance with NICE guideline CG19, taking into account periodontal status, smoking history, oral hygiene, and overall clinical risk — not HbA1c level alone. Recall intervals may range from three to twenty-four months depending on assessed risk.

How Poor Gum Health Can Affect Blood Sugar Control

Active periodontitis releases pro-inflammatory cytokines into the bloodstream that promote insulin resistance, raising blood glucose levels and making HbA1c targets harder to achieve.

The relationship between gum disease and blood sugar is not one-directional. There is robust evidence to suggest that active periodontal infection can independently worsen glycaemic control, making it harder for people with diabetes to achieve their HbA1c targets.

The mechanism centres on systemic inflammation. Periodontitis is a chronic bacterial infection that triggers the release of pro-inflammatory cytokines — including interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-α) — into the bloodstream. These inflammatory mediators promote insulin resistance, impairing the body's ability to use glucose effectively. The result is a sustained elevation in blood glucose levels, which in turn feeds back to worsen the oral infection — a damaging cycle that can be difficult to break without addressing both conditions simultaneously.

Clinical trials have provided encouraging evidence that treating gum disease can lead to modest but meaningful reductions in HbA1c. The most authoritative synthesis of this evidence is the Cochrane Review by Simpson and colleagues (updated 2022), which found that periodontal treatment was associated with an average HbA1c reduction of approximately 0.4% (around 4 mmol/mol) at three to four months in adults with type 2 diabetes. The long-term durability of this effect remains uncertain, and the evidence is strongest for type 2 diabetes; data in type 1 diabetes are more limited. Whilst the magnitude of effect is modest, it is clinically meaningful and supports the value of periodontal care as part of broader diabetes management.

Patients should be informed that:

• Untreated gum disease may be contributing to difficulty controlling blood sugar

• Dental treatment is not merely cosmetic — it has systemic health implications

• Coordinated care between dental and medical teams can improve outcomes for both conditions

NHS Guidance on Dental Care for People with Diabetes

NICE guideline NG28 recommends that people with type 2 diabetes are advised of their increased periodontal risk and encouraged to attend dental check-ups; recall intervals should be determined individually in line with NICE CG19.

The NHS and NICE both recognise the importance of oral health in people with diabetes. NICE guideline NG28 advises healthcare professionals to discuss the increased risk of periodontal disease with people with type 2 diabetes and to recommend a dental appointment if the patient has not attended within the last twelve months. Specific periodontal care pathways continue to evolve within integrated care frameworks.

People with diabetes are entitled to NHS dental care on the same basis as the general population. They do not currently receive free NHS dental treatment solely on the grounds of their diabetes diagnosis, though those receiving certain benefits or on low incomes may qualify for free or reduced-cost dental care under the NHS Low Income Scheme (HC1/HC2 certificates). Further information is available on the NHS website.

Key recommendations for people with diabetes include:

• Attending dental check-ups at intervals recommended by their dentist, based on individual risk in line with NICE CG19 — this may be more frequent than once a year for those with active gum disease or other risk factors

• Informing the dentist of their diabetes diagnosis and most recent HbA1c level

• Disclosing all medications, including insulin and oral hypoglycaemic agents, as these may affect treatment planning

• Maintaining good oral hygiene — brushing twice daily with fluoride toothpaste and cleaning between teeth daily

For patients undergoing dental procedures, the dental team should be aware of the risk of hypoglycaemia, particularly in those taking insulin or sulphonylureas. Appointments are best scheduled in the morning after a normal meal and usual medication routine. Patients should be advised to bring fast-acting glucose (such as glucose tablets or a sugary drink) to their appointment. For information on specific medicine interactions or precautions, clinicians should consult the relevant Summary of Product Characteristics (SmPC) via the MHRA/emc. Suspected adverse drug reactions should be reported via the MHRA Yellow Card scheme.

When to See Your GP or Dentist About Gum Disease

Bleeding gums, persistent bad breath, gum recession, or loose teeth in a person with diabetes warrant a prompt dental appointment; facial swelling, difficulty swallowing, or signs of sepsis require same-day emergency care.

Recognising the early signs of gum disease is particularly important for people with diabetes, as the condition can progress more rapidly and with less obvious symptoms than in the general population. Prompt action can prevent irreversible damage to the supporting structures of the teeth and help protect overall glycaemic control.

Signs that warrant a prompt dental appointment include:

• Gums that bleed when brushing or flossing

• Persistent bad breath (halitosis) that does not resolve with oral hygiene

• Red, swollen, or tender gum tissue

• Gums that appear to be receding or pulling away from the teeth

• Loose or shifting teeth

• Pain when chewing

• Pus between the teeth and gums

If any of these symptoms are present, patients should contact their dentist without delay. In cases where a dental abscess is suspected — characterised by severe throbbing pain, facial swelling, fever, or difficulty swallowing — urgent same-day dental or medical attention is required. Additional urgent red flags that require immediate emergency care include rapidly spreading facial swelling, difficulty opening the mouth (trismus), difficulty swallowing or breathing, or signs of systemic sepsis. NHS 111 can advise on emergency dental services if a regular dentist is unavailable.

For patients with severe or complex periodontal disease (for example, those with a Basic Periodontal Examination score of 4, furcation involvement, or stage III/IV periodontitis), referral to a specialist periodontal service may be appropriate, in line with BSP referral guidance.

From a GP perspective, a discussion with the diabetes care team is warranted if:

• HbA1c has risen unexpectedly without a clear dietary or medication explanation

• The patient reports recurrent oral infections or slow healing after dental procedures

• There are signs of systemic infection originating from the mouth

• Severe periodontitis is identified in a patient not known to have diabetes, prompting consideration of HbA1c testing

Healthcare professionals should proactively ask about oral health at diabetes reviews, as patients may not volunteer dental symptoms or appreciate their relevance to blood sugar management.

Improving HbA1c and Gum Health Through Lifestyle Changes

Smoking cessation, a low-sugar diet, regular physical activity, and twice-daily brushing with interdental cleaning can meaningfully improve both HbA1c and periodontal health simultaneously.

Encouragingly, many of the lifestyle modifications that improve glycaemic control also benefit periodontal health, making a combined approach both practical and effective. Patients should be supported to understand that small, consistent changes can have a meaningful impact on both their HbA1c and the health of their gums.

Diet and weight management play a central role. Reducing intake of refined sugars and ultra-processed foods lowers blood glucose fluctuations and also reduces the substrate available for oral bacteria to produce the acids that damage gum tissue. A diet rich in vegetables, wholegrains, lean protein, and healthy fats — consistent with NHS Eatwell Guide principles — supports both metabolic and oral health.

Smoking cessation is arguably the single most impactful lifestyle change for both conditions. Smoking is an independent risk factor for periodontitis and significantly impairs the response to periodontal treatment. It also worsens insulin resistance and cardiovascular risk. NHS Stop Smoking Services offer free, evidence-based support. NICE guideline NG209 recommends a combination of behavioural support and pharmacotherapy, which may include nicotine replacement therapy (NRT), varenicline, or bupropion. Clinicians should check current UK formulary availability and local prescribing guidance, as the supply of individual medicines may vary.

Physical activity improves insulin sensitivity and reduces systemic inflammation — both of which benefit gum health indirectly. UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week for adults, alongside muscle-strengthening activities on at least two days per week. NICE guideline NG28 supports these targets for adults with type 2 diabetes.

From an oral hygiene perspective, patients should be encouraged to:

• Brush teeth for two minutes, twice daily using a fluoride toothpaste

• Use interdental brushes or floss daily to remove plaque from between teeth

• Consider using a chlorhexidine mouthwash short-term if advised by a dentist during active gum disease treatment — patients should be aware that short courses may cause temporary tooth staining, taste disturbance, and mild mucosal irritation, and should follow their dentist's instructions; for full prescribing information, refer to the MHRA/emc SmPC (e.g., Corsodyl 0.2%)

• Stay well hydrated to support saliva production

By addressing lifestyle factors holistically, patients can achieve meaningful improvements in both their HbA1c readings and their long-term oral health outcomes. Suspected adverse reactions to any medicine should be reported via the MHRA Yellow Card scheme.

Experiencing these side effects? Our pharmacists can help you navigate them →

Frequently Asked Questions